Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat

Title: Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat

Volume: 7 Issue: 1

Author(s): J.-P. Chaput, S. St-Pierre and A. Tremblay

Affiliation:

Keywords: Pharmacotherapy, sibutramine, orlistat, body weight, fat, energy balance, physical activity, diet

Abstract: The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and gastrointestinal adverse effects are however not negligible.

Cite this article as:

Chaput J.-P., St-Pierre S. and Tremblay A., Currently Available Drugs for the Treatment of Obesity: Sibutramine and Orlistat, Mini-Reviews in Medicinal Chemistry 2007; 7 (1) . https://dx.doi.org/10.2174/138955707779317849